Metsera, Inc., a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases, today announced positive topline results from the Phase 1 ...

Recently debuted Metsera is unfolding some phase 1 data for its GLP-1 receptor agonist, revealing a 7.5% reduction in body ...

Chad Jessup, who previously worked on Destiny 2 expansions and the Xbox 360 version of Shadowrun, posted about emptying his ...

There are reasons to believe Half-Life 3 might be in the works, but before it gets here, more people need to play Valve’s ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Few medications have become as popular and culturally relevant as Ozempic has, but how exactly do it and similar drugs affect ...